DrugPatentWatch Database Preview
Details for New Drug Application (NDA): 018676
Email this page to a colleague
» See Plans and Pricing
NDA 018676 describes HEPATAMINE 8%, which is a drug marketed by B Braun and is included in one NDA. It is available from one supplier. Additional details are available on the HEPATAMINE 8% profile page.
The generic ingredient in HEPATAMINE 8% is amino acids. There are three hundred and fifty drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the amino acids profile page.
The generic ingredient in HEPATAMINE 8% is amino acids. There are three hundred and fifty drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the amino acids profile page.
Summary for 018676
| Tradename: | HEPATAMINE 8% |
| Applicant: | B Braun |
| Ingredient: | amino acids |
| Patents: | 0 |
| Formulation / Manufacturing: | see details |
Suppliers and Packaging for NDA: 018676
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| HEPATAMINE 8% | amino acids | INJECTABLE;INJECTION | 018676 | NDA | B. Braun Medical Inc. | 0264-9371 | 0264-9371-55 | 6 CARTON in 1 CASE (0264-9371-55) > 1 CONTAINER in 1 CARTON > 500 mL in 1 CONTAINER |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 8% (8GM/100ML) | ||||
| Approval Date: | Aug 3, 1982 | TE: | RLD: | No | |||||
Expired US Patents for NDA 018676
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| B Braun | HEPATAMINE 8% | amino acids | INJECTABLE;INJECTION | 018676-001 | Aug 3, 1982 | Start Trial | Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription
